Cronos Group (CRON) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is CRON's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

Altria remains fundamentally well-positioned for U.S. cannabis entry, primarily through its 42% stake in Cronos Group. MO's core tobacco business continues to generate robust cash flow, with Q2 2026 adjusted EPS up 2.8% …

Cronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript…

Shares of Cronos Group Inc. (NASDAQ: CRON - Get Free Report) hit a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement. The company traded as high as $3.71 and last …

Cronos Group NASDAQ: CRON reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in Europe following the co…

Cronos Group (CRON) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.07 per share a year ago.…

Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count…

BKR secures an E subsea contract for Cyprus' Cronos gas project, strengthening its deepwater backlog and revenue prospects.…

HOUSTON and LONDON, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Wednesday a significant contract from Eni to provide subsea production systems and services for it…

Here is how Cronos Group (CRON) and Amgen (AMGN) have performed compared to their sector so far this year.…

Cronos (CRON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).…

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027…

TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popul…

Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.…

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET…

Cronos Group (NASDAQ: CRON - Get Free Report) and Eton Pharmaceuticals (NASDAQ: ETON - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based…

Bank of America Corp DE bought a new position in Cronos Group Inc. (NASDAQ: CRON) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 157,631 shares of the company's stoc…

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript…

Cronos Group NASDAQ: CRON used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international exp…

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growi…

Cronos Group (NASDAQ: CRON - Get Free Report) and Lyra Therapeutics (OTCMKTS:LYRA - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based o…

Cronos Group Inc. is upgraded to a Buy, driven by a best-in-class balance sheet and improved profitability. CRON boasts $827 million in cash, no debt, and strong international expansion, with adjusted gross margins reach…

Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is now open for Cronos' first Investor Day, which will be hosted by the Cron…

Here is how Cronos Group (CRON) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.…

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Ras…

A rate hike could keep markets volatile, making BVS, CNC, AMRX and CRON healthcare stocks to consider as inflation stays elevated.…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.

